10 October 2022>: Database Analysis
Activation of Tumor-Associated Macrophages via Promotes Recurrence of Oral Squamous Cell Carcinoma
Chen-xi Li 123ABCDEF* , Ying Su 4ABCD , Zhong-cheng Gong 123ACDG* , Hui Liu 56ACDDOI: 10.12659/MSM.937126
Med Sci Monit 2022; 28:e937126
Table 1 The GO and KEGG enrich terms.
Term | Fold enrichment | p-Value | Count |
---|---|---|---|
Transcription, DNA-templated | 1.68 | 0.00 | 40 |
Negative regulation of granulocyte differentiation | 30.72 | 0.00 | 3 |
Protein targeting to vacuole | 30.72 | 0.00 | 3 |
Golgi to plasma membrane protein transport | 12.14 | 0.00 | 4 |
Positive regulation of neuron projection development | 5.52 | 0.00 | 6 |
Somatic stem cell population maintenance | 6.30 | 0.01 | 5 |
Blood vessel development | 8.62 | 0.01 | 4 |
Positive regulation of I-kappaB kinase/NF-kappaB signaling | 3.56 | 0.01 | 7 |
Lymph node development | 14.46 | 0.02 | 3 |
activation of MAPKK activity | 7.12 | 0.02 | 4 |
Positive regulation of type I interferon production | 6.42 | 0.02 | 4 |
Development of secondary female sexual characteristics | 81.91 | 0.02 | 2 |
Viral process | 2.47 | 0.03 | 9 |
Positive regulation of erythrocyte differentiation | 10.24 | 0.03 | 3 |
Response to tumor necrosis factor | 9.83 | 0.04 | 3 |
Peptidyl-tyrosine phosphorylation | 3.21 | 0.04 | 6 |
Endodermal cell differentiation | 9.10 | 0.04 | 3 |
Glutamate secretion | 8.78 | 0.05 | 3 |
Hematopoietic progenitor cell differentiation | 4.96 | 0.05 | 4 |
Creatinine metabolic process | 40.96 | 0.05 | 2 |
Positive regulation of viral transcription | 8.47 | 0.05 | 3 |
Transcription from RNA polymerase II promoter | 1.92 | 0.05 | 12 |
Nucleus | 1.45 | 0.00 | 92 |
Cytoplasm | 1.38 | 0.00 | 84 |
Cytosol | 1.52 | 0.00 | 59 |
Nucleoplasm | 1.57 | 0.00 | 51 |
Microtubule organizing center | 3.91 | 0.01 | 7 |
Neuron projection terminus | 19.74 | 0.01 | 3 |
Apical part of cell | 5.70 | 0.01 | 5 |
Centrosome | 2.41 | 0.01 | 12 |
Spindle | 4.24 | 0.01 | 6 |
Trans-Golgi network membrane | 5.15 | 0.02 | 5 |
Midbody | 3.98 | 0.02 | 6 |
Trans-Golgi network | 3.77 | 0.02 | 6 |
Microtubule | 2.48 | 0.03 | 9 |
Membrane raft | 2.91 | 0.03 | 7 |
TAP complex | 57.04 | 0.03 | 2 |
Recycling endosome | 3.89 | 0.04 | 5 |
Lysosomal membrane | 2.50 | 0.04 | 8 |
Protein binding | 1.24 | 0.00 | 127 |
Receptor signaling protein serine/threonine kinase activity | 9.70 | 0.00 | 6 |
Transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding | 13.71 | 0.00 | 4 |
RNA polymerase II distal enhancer sequence-specific DNA binding | 6.59 | 0.01 | 5 |
Metal ion binding | 1.53 | 0.01 | 37 |
Poly(A) RNA binding | 1.67 | 0.02 | 22 |
Activin-activated receptor activity | 85.69 | 0.02 | 2 |
Transferase activity | 4.46 | 0.03 | 5 |
Peptide antigen-transporting ATPase activity | 57.13 | 0.03 | 2 |
TAP1 binding | 42.85 | 0.05 | 2 |
Tuberculosis | 3.49 | 0.01 | 8 |
TNF signaling pathway | 4.33 | 0.01 | 6 |
Focal adhesion | 3.00 | 0.02 | 8 |
Neurotrophin signaling pathway | 3.86 | 0.02 | 6 |
Viral myocarditis | 5.42 | 0.04 | 4 |
MAPK signaling pathway | 2.44 | 0.04 | 8 |
Apoptosis | 4.99 | 0.04 | 4 |
Viral carcinogenesis | 2.64 | 0.05 | 7 |